In humans, the composition of gut commensal bacteria is closely correlated with obesity. The bacteria modulate metabolites and influence host immunity. In this study, we attempted to determine whether there is a direct correlation between specific commensal bacteria and host metabolism. As mice aged, we found significantly reduced body weight and fat mass in Atg7
INTRODUCTION
Obesity is linked worldwide to type 2 diabetes, cardiovascular disorders, cancer, and asthma. 1 Trials to assess potential obesity treatments are complicated by life styles and genetic polymorphisms; however, energy imbalance is an obvious cause. 2 Therefore, many scientists have sought environmental factors that influence energy balance.
Autophagy, the self-digesting pathway, is best known as an innate adaptation to starvation. 3 Its mechanisms have indispensable roles in the maintenance of host homeostasis by removing misfolded proteins and damaged organelles. 4 In recent years, autophagy has been implicated in several pathological and physiological conditions including infectious and autoimmune diseases, cancer, and metabolic disorders that include obesity. 5 Previous studies demonstrated that inhibition of autophagy in vitro with 3-methylademine leads to increased triglycerides and lipid droplet accumulation in hepatocytes, 6 and that the defective hepatic autophagy-related gene 7 (Atg7) in conjunction with obesity causes insulin resistance. 7 On the other hand, adipose-specific Atg7-deleted mice exhibit lower body weight, decreased white adipose tissues, and increased insulin sensitivity, all of which contribute to diet-induced obesity. 6, 8 In addition, skeletal muscle-specific Atg7-deleted mice have ''lean'' phenotypes supported by decreased fat mass and amelioration of insulin resistance, 9 indicating that autophagy is a key mechanism for regulation of host lipid metabolism. However, we still do not know whether controlling the autophagy pathway could be an environmental factor for regulation of energy balance.
Obesity is associated with substantial changes in the composition and metabolic function of the gut microbiota, which may have therapeutic potential. 10 In initial studies, data from mice models and human volunteers with lean and obese phenotypes showed that changes in the relative abundance of specific phyla such as Firmicutes and Bacteroidetes are associated with obesity. 11, 12 It has been hypothesized that variations in abundance of gut microbiota result in different yields of energy from the diet. 12 Mice deficient in TLR5 develop metabolic syndromes that include insulin resistance and increased adiposity. These are closely correlated with changes in the composition of their gut microbiota. 13 Moreover, alteration in gut microbiota by antibiotic treatment increases host adiposity 14 and gnotobiotic mice given fecal microbiota from obese or lean volunteers representing donor's phenotypes. 15 In terms of energy expenditure, commensal microbes can contribute to obesity by providing digestive enzymes, by regulating fat storage, 16 and by producing short-chain fatty acids (SCFAs). 8 In this study, we identified lean phenotypes in Atg7
DCD11c
mice that had improved insulin resistance and lower body weight and fat mass. Remarkably, these phenotypes were dependent on expansion of a specific commensal bacterium, Bacteroides acidifaciens (BA), which subsequently altered the commensal bacteria community. Of note, BA administration resulted in amelioration of metabolic disorders in the mice. Our results suggest that BA may be a potential agent for modulating metabolic disorders such as diabetes and obesity.
RESULTS

Atg7
DCD11c mice showed lean phenotypes with reduced body weight and fat mass
To address the role of autophagy in the immune cells for development of metabolic disorders, we monitored body weight and behavior of Atg7 conditional knockout mice in dendritic cells (Atg7 DCD11c ), in gut epithelial cells (Atg7 Dvillin ), and in macrophages (Atg7 DLysM ). Mice were fed with normal chow diet (NCD). As mice aged, we unexpectedly found that the difference in body weight between Atg7 DCD11c mice and their control littermates (Atg7 flox/flox(f/f) ) gradually increased ( Figure 1a) . No significant changes in body weight were found in Atg7
Dvillin or Atg7 DLysM mice (data not shown). Of note, 24-week-old Atg7
DCD11c mice had significantly lower body weight and fat mass than Atg7 f/f mice (Figure 1a,b) . Both male and female mice had lean phenotypes (Atg7 DCD11c ; Supplementary Figure 1 online) . Magnetic resonance imaging analysis further revealed that the abdominal adipose tissue masses in both axial and coronal directions were significantly reduced in the Atg7
DCD11c mice when compared with the littermate Atg7 f/f mice ( Figure 1c ). In addition, the size of a single adipocyte in visceral adipose tissues obtained from Atg7
DCD11c mice was significantly smaller than that of Atg7 f/f mice ( Figure 1d ). We also found that high fat diet (HFD)-fed Atg7
DCD11c mice had reduced body weight when compared with the HFD-Atg7 f/f mice (Supplementary Figure 2 ). To clarify the involvement of systemic and mucosal inflammation in the lean phenotype Atg7 DCD11c mice, we measured proinflammatory cytokine levels in serum and mRNA expression of F4/80 and TNFa in visceral adipose tissues and did histological analyses of small and large intestines. We found similar or even decreased levels of several indicators of systemic and mucosal inflammation in the Atg7 DCD11c mice, indicating the lean phenotype chronically shown in Atg7
DCD11c mice is not associated with inflammation (Supplementary Figure 3) . Of note, higher insulin and subsequent lower glucose levels were detected in the serum of Atg7
DCD11c mice than in Atg7 f/f mice under non-fasting conditions (Figure 1e) . Insulin resistance as determined by glucose tolerance test (GTT) and insulin tolerance test (ITT) was significantly improved in Atg7
DCD11c mice when compared with littermate Atg7 f/f mice ( Figure 1f) . Taken together, these data indicate that aged Atg7
DCD11c mice had lean phenotypes with reduced fat mass and improved glucose homeostasis.
Low levels of SCFAs in feces of Atg7
DCD11c mice
Because aged Atg7 DCD11c mice had decreased body weight and fat mass, we next conducted metabolome analysis by capillary electrophoresis time-of-flight mass spectrometry (CE-TOF-MS) and gas chromatography mass spectrometry in feces for correlation between lean phenotypes and energy utilization. Although principal component analysis showed a weak correlation (data not shown), individual plots of Atg7
DCD11c mice in orthogonal partial least squares discriminate analysis were clearly segregated from those of Atg7 f/f mice (Supplementary Figure 4A) . Moreover, some SCFAs, such as acetate, butyrate, propionate, and lactate, were located at remote spots from the axis (Supplementary Figure 4B) , indicating that those factors contribute to separating Atg7 f/f and Atg7 DCD11c mice. Indeed, the amounts of fecal acetate, butyrate, and propionate in Atg7 DCD11c mice were significantly decreased, whereas the lactate level in Atg7
DCD11c mice was higher than in Atg7 f/f mice (Supplementary Figure 4C) .
Commensal bacteria are associated with the lean phenotype of aged Atg7
To address whether commensal bacteria are related to the lean phenotype of Atg7 DCD11c mice, we used co-housing (CH) and fecal microbiota transplantation (FMT) experiments. Beginning at birth, Atg7
DCD11c and Atg7 f/f mice shared cages and were exposed to feces. The Atg7 f/f mice that shared cages with Atg7
DCD11c mice gained less body weight and fat than the Atg7 f/f mice that did not share cages (Figure 2a ,b; Supplementary Figure 5 ). Also, the Atg7 DCD11c mice that shared cages with Atg7 f/f mice gained more body weight and fat than the Atg7 DCD11c mice that did not share cages (Figure 2a ,b; Supplementary Figure 5 ). To confirm whether the phenotype of CH mice is mediated by commensal microorganisms, after the CH experiment, we moved mice to individual cages. As shown in Figure 2c , the Atg7 DCD11c mice gained less body weight when they were housed alone but the Atg7 f/f mice did not. In addition, wild-type B6 mice orally given
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fecal extract from Atg7 DCD11c mice daily for 12 weeks had significantly lower body weight and fat mass than those transferred from wild-type B6 or Atg7 f/f mice ( Figure 2d ). Of note, wild-type B6 mice given fecal extracts from Atg7 DCD11c mice had higher insulin levels and subsequently lower serum glucose levels than those that received extracts from Atg7 f/f mice ( Figure 2e) . Overall, these results imply that commensal bacteria have an indispensable role in the lean phenotype of Atg7 DCD11c mice.
Expansion of BA in feces of Atg7 DCD11c mice
To see the diversity and composition of gut commensal bacteria, we next adopted metagenomic analysis. In pyrosequencing analysis, the proportion of Bacteroidetes, Firmicutes, and Proteobacteria, the primary populations of gut microbiota at the phylum level, was similar in the feces of Atg7 f/f and Atg7 DCD11c mice (Figure 3a) . The proportion of Bacteroidia (class), Bacteroidales (order), Bacteroidaceae (family), and Bacteroides (genus) was also similar or not significantly 
f) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in male Atg7
f/f and Atg7 DCD11c mice (total n ¼ 7). Data shown are the mean values ± s.e.m. from individual mice from 3 independent experiments with 3-4 mice per experiment. Statistical analyses were done with two-tailed paired t-test (a-right, d, and e) and two-way ANOVA with Bonferroni post hoc test (a-left and f). *Po0.05, **Po0.01, and ***Po0.001. changed ( Figure 3b ). However, when we analyzed species levels, the ratio of BA was significantly greater in the feces of Atg7 DCD11c mice than in Atg7 f/f mice (5.48 ± 1.76% vs. 0.77 ± 0.18%) ( Figure 3c , red arrow; Supplementary  Figures 6 and 7) . On the other hand, the proportion of other Bacteroides species, including B. sartorii, in the commensal bacteria was not altered in the feces of Atg7
DCD11c or Atg7 f/f mice (Supplementary Figure 7) . In alpha diversity, while the species richness (Chao 1 index) of fecal microbiota of Atg7
DCD11c mice was significantly decreased, the community diversity (Shannon/Simpson index) was similar to those of Atg7 f/f mice (Supplementary Table) . To further confirm the expansion of BA in Atg7
DCD11c
mice with lean phenotype, we used fluorescence in situ hybridization analysis. As shown in Figure 3d , increased numbers of BA were detected in the lumen of the colon and few BA were internalized in the colonic epithelial cells of Atg7 DCD11c mice. We also found expansion of BA in the feces of Atg7 f/f mice co-housed with Atg7
DCD11c mice (Supplementary Figure 8) . Taken together, these findings show that among commensal bacteria, BA is magnified in the gut of Atg7
DCD11c mice with lean phenotype.
Oral administration of BA leads to lean phenotypes in HFDfed B6 mice
To clarify whether expanded BA can regulate lipid metabolisms, we obtained BA (JCM10556), cultured the organisms to obtain a large volume, and fed them to naive B6 mice. To determine optimal conditions for administration, we quantified BA in colon tissue and feces of mice fed with BA (5 Â 10 9 CFU per 100 ml) by fluorescence in situ hybridization analysis. Numerous BA were detected in the lumen of colon epithelium cells 1 day following oral administration (Supplementary Figure 9A) . The number of BA recovered from feces peaked 2 Figure 11) . In addition, the size of a single adipocyte in epididymal adipose tissue of BA-and HFD-fed B6 mice was significantly smaller than that of PBS-and HFD-fed mice (Figure 4d ). In addition, insulin resistance as determined by GTT and ITT was significantly improved in BA-and HFD-fed mice as compared with PBS-and HFD-fed mice (Figure 4e ).
To further assess the effects on hepatic and peripheral insulin sensitivity by feeding with BA, we employed a hyperinsulinemic-euglycemic clamp technique with heat-inactivated BA as a control. Interestingly, BA feeding improved both hepatic and peripheral insulin sensitivity, while heat-inactivated BA showed similar, but not statistically significant, effects (Supplementary Figure 12) . Oral administration of BA reduced butyrate in the feces of NCD-fed mice, but no significance differences were found in the levels of acetate, propionate, and lactate (Supplementary Figure 13A) . Similar tendencies were observed in the HFD-fed groups (Supplementary Figure 13B) . To further assess DCD11c mice determined by fluorescence in situ hybridization probe specific for BA (total n ¼ 5). Scale bar ¼ 100 mm. White arrow indicates representative BA. Data shown are the mean values±s.e.m. from individual mice from 2 independent experiments with 2-3 mice per experiment. Statistical analyses were done with two-tailed paired t-test. *Po0.05; ns, not significant. energy expenditure, activity, and substrate utilization, we next monitored mice fed with BA after being housed individually in comprehensive laboratory animal monitoring system cages for 5 days. Although groups of mice fed with PBS or BA exhibited a similar locomotor activity and respiratory exchange ratio, BAand HFD-fed mice expanded more energy than PBS-and HFDfed mice (Figure 4f) . NCD-fed mice given oral BA showed similar effects, except for energy expenditure (Supplementary Figure 10) . Collectively, long-term administration of BA promoted energy expenditure and consequently caused dominant lean phenotypes in diet-induced obese mice.
Mice with lean phenotypes exhibit enhanced peroxisome proliferator-activated receptor a expression in adipose tissues
Because decreased body weight and fat mass were detected in Atg7
DCD11c , FMT B6, and BA-fed B6 mice, we further analyzed gene expression levels as related to lipid metabolism in adipose tissue, liver, and the small intestine. Of note, gene expression related to lipid b-oxidation, especially peroxisome proliferatoractivated receptor alpha (PPARa), was significantly enhanced only in the epididymal adipose tissues of Atg7 DCD11c mice (Figure 5a) . We found no significant changes in this gene in the small intestine and liver (Supplementary Figure 14A and B) . Consistent with these results, expression of PPARa was significantly upregulated in epididymal adipose tissues of B6 mice given fecal extracts of Atg7
DCD11c mice or fed with HFD and BA for 10 weeks (Figure 5b,c) . To clarify whether enhanced b-oxidation levels are directly activated by bacteria alone and are not the product of lean phenotypes, we next tested PPARa expression levels in B6 mice following BA administration in a time-dependent manner. Of interest, mRNA levels of PPARa in epididymal adipose tissues of B6 mice were significantly enhanced 2 weeks after BA administration (Figure 5d) . We also assessed the expression levels of TGR5, a G-protein-coupled bile acid receptor that can stimulate energy expenditure through PPARa activation. 17, 18 We found elevated TGR5 expression levels in adipose tissues following BA administration (Figure 5e ). These results suggest that lean phenotypes mediated by BA might begin with lipid oxidation in adipose tissue through TGR5-PPARa activation. Expression level of mRNA genes as related to fatty acid synthesis (FasN, HSL, PEPCK, SCD1, and PPARg), b-oxidation (PPARa), and thermogenesis (PRDM16, PGC1a, Cidea, and GLUT4) was determined by real-time PCR using epididymal adipose tissues of Atg7 f/f and Atg7 DCD11c mice (a; total n ¼ 8), fecal microbiota transplanted mice (b; total n ¼ 8), and BA-fed mice (c; total n ¼ 8) at the end point of each experiment. Expression levels of PPARa (d) and TGR5 (e) in adipose tissue were analyzed by RT-PCR 1, 7, and 14 days after daily BA administration. Data shown are the mean values±s.e.m. from individual mice from 2 independent experiments with 3-5 mice per experiment. Statistical analyses were done with two-way ANOVA with Bonferroni post hoc test (a-c) and with Mann-Whitney t-test (d, e). *Po0.05, **Po0.01, ***Po0.001; ns, not significant.
BA modulates glucagon-like peptide-1 production by regulating dipeptidyl peptidase-4 and by producing bile acids
We further addressed the role of BA in the regulation of glucose homeostasis. As expected, BA-fed B6 mice showed higher insulin and lower glucose levels in serum than PBS-fed B6 mice, although glucose levels were not significant in BA-and NCDfed B6 mice (Figure 6a) . To investigate the possibility that these increased plasma insulin levels might also be a sign of b-cell overstimulation, we stained a-and b-cells in the pancreas tissues 10 weeks after BA feeding. We found that BA feeding did not elicit b-cell overstimulation that might lead to premature b-cell failure (Supplementary Figure 15) . To investigate the underlying mechanism of high levels of insulin secretion in BAfed lean mice, we next studied the glucagon-like peptide-1 (GLP-1) levels that could stimulate insulin release to blood. 19 The GLP-1 levels in serum were dramatically enhanced following administration of BA in NCD-and HFD-fed mice (Figure 6b) . Of note, the levels of dipeptidyl peptidase-4 (DPP-4), a well-known enzyme that causes degradation of GLP-1, 20 were decreased in the small intestine ileum after oral administration of BA or culture supernatants (Figure 6c ).
In addition, we measured DPP-4 activity that reflects protein quantity (data not shown). Previous studies suggested that bile acids have a pivotal role in glucose homeostasis by stimulating GLP-1 secretion through TGR5 activation. 21, 22 We found significantly increased levels of cholate, salts of cholic acid (CA), and taurine deconjugated from primary bile acid in feces of B6 mice fed with BA for 10 weeks but no significant loss of cholesterol (Figure 6d; Supplementary Figure 16 ). In addition, we obtained significantly higher levels of bile acids (i.e., cholate and taurine as shown in red box) in Atg7
DCD11c mice among the 292 metabolites analyzed by CE-TOF-MS (Supplementary Figure 17) . These results indicate that BA or its metabolites may reduce DPP-4 enzyme activity and subsequently result in GLP-1 activation, improving insulin sensitivity and glucose tolerance.
DISCUSSION
In this study, we found that specific gut commensal bacteria (i.e., BA) was expanded in Atg7 adipose tissues, which may lead to high energy expenditure. At the same time, BA activates DPP-4 in the gut and subsequently increase GLP-1, which may contribute to glucose homeostasis. Bile acids, cholate, and taurine may also contribute to GLP-1 activation through the TGR5 receptor and result in improved insulin sensitivity. Overall, BA may have a role in prevention of metabolic diseases such as diabetes and obesity ( Figure 7) . BA have been isolated from mouse ceca 23 and human feces. 24 These novel commensal bacteria are characterized as anaerobic and Gram negative. They increase IL-6 and IL-10 production by enhancing expression of MHC class II molecules and also costimulate molecules (i.e., CD80 and CD86) on antigenpresenting cells. 25 BA is one of the predominant commensal bacteria that promote IgA antibody production in the large intestine. Specifically, it induces activation-induced cytidine deaminase expression. 26, 27 In this study, we discovered that BA can also modulate insulin resistance and energy metabolism and thus that it may be of therapeutic value for treating metabolic diseases such as diabetes and obesity.
An investigation of the epidemiologic relationship between obesity and its causes found that environmental factors and host genetic background can influence the composition of gut commensal bacteria. 28 The majority of gut commensal microbiota in mammals are Bacteroidetes and Firmicutes. Human and animal studies suggest that a higher ratio of Firmicutes to Bacteroidetes enables greater efficiency of gut microbiota in extracting energy from the diet, which can be one cause of adiposity. 11, 14, 29 Others suggest that such alteration at the phylum level is insufficient to explain the mechanisms associated with adiposity and obesity. 30, 31 Those observations support our current findings. We found no changes in the proportion of Firmicutes and Bacteroidetes in feces of Atg7 DCD11c mice, which are prone to lean phenotypes unlike their littermate Atg7 f/f mice (Figure 3a) . Instead, we found that specific species (i.e., BA) among the Bacteroidetes phylum were largely expanded in the lean Atg7
DCD11c mice (Figure 3c) . A recent study revealed that obese mice co-housed with mice containing a lean twin's microbiota did not have body weight increases and obesity-associated metabolic phenotypes that Figure 7 Proposed models of ''lean bug'' B. acidifaciens (BA) to protect host against insulin sensitivity and obesity. One gut commensal bacteria (i.e., BA) was expanded in Atg7
DCD11c mice with lean phenotypes. BA feeding resulted in activation of fat oxidation through the bile acid-TGR5-PPARa axis in adipose tissues, which may lead to high energy expenditure. At the same time, BA activates dipeptidyl peptidase-4 (DPP-4) in the gut and subsequently increases glucagon-like peptide-1 (GLP-1), which may contribute to glucose homeostasis. Bile acids (i.e., cholate and taurine) may also contribute to GLP-1 activation through TGR5 and result in improved insulin sensitivity. PPARa, peroxisome proliferator-activated receptor a; SCFAs, short-chain fatty acids.
were correlated with Bacteroides such as B. cellulosilyticus, B. uniformis, B. vulgatus, B. thetaiotaomicron, and B. caccae. 15 Furthermore, oral administration of B. uniformis CECT 7771 strain reduced metabolic disorders and immunological dysfunction in HFD-induced obese mice. 32 In the present study, we first identified BA, which are associated with gut microbiota homeostasis, for energy harvest.
We believe that BA may be tightly regulated by the autophagy mechanism of CD11c þ cells at the steady-state condition. Indeed, we found higher numbers of BA in the Atg7-deficient CD11c þ mice than in the Atg7-sufficient mice when cells were co-cultured in vitro with BA for 24 h (Supplementary Figure 18) . In support of these results, previous studies showed that the autophagy-dependent pathway is crucial for intracellular bacteria digestion as observed in Atg16L1-deficient dendritic cells. 33, 34 The gastrointestinal tract is a locus of incretin hormone products such as GLP-1 that stimulate insulin release and decrease blood glucose levels. 19 GLP-1 is inactivated by the enzyme DPP-4 and thus DPP-4 inhibitor is a class of oral hypoglycemic. 20 We found similar patterns of low glucose and high insulin levels in the serum of Atg7
DCD11c mice with high numbers of BA, in FMT mice, and in BA-fed mice (Figures 1e,  2e , and 6a). Of note, there were significantly decreased levels of DPP-4 in the gut with increased levels of GLP-1 in the serum of BA-fed mice (Figure 6b,c) . It seems likely that unknown metabolites synthesized by BA or by other bacteria may directly interact with gut epithelial cells and inhibit DPP-4 activation, thereby increasing circulating GLP-1.
Two general cascades are associated with lower weight gain, reduced energy utilization/storage efficiency, and increased energy expenditure. The metabolome analysis by CE-TOF-MS and gas chromatography mass spectrometry revealed clear segregation between Atg7
DCD11c and Atg7 f/f mice (Supplementary Figure 4A) . Loading plots showed SCFAs such as butyric, propionic, and acetic acids were significantly lower and conversely that lactic acid was higher in Atg7 DCD11c mice than in Atg7 f/f control mice (Supplementary Figure 4C ). This SCFA profile is similar to that of specific pathogen-free mice fed a low-fiber diet. 35 As reported, caloric extraction from diet fiber is upregulated in obese animals and humans compared with healthy controls. 36 Young mice administered subtherapeutic doses of antibiotics had increased adiposity and substantially increased SCFAs in cecal contents.
14 Thus, we assume that the altered microbiota of Atg7
DCD11c mice (i.e., lower richness (Supplementary Table) and expansion of BA) is related to poor caloric extraction in contrast to that of control Atg7 f/f mice. Given that SCFAs are good energy sources for the host, decreased SCFA levels may reduce energy supply and result in lean phenotypes.
PPARa is a nuclear receptor that contributes to regulate lipid metabolism. 37 Earlier studies demonstrated that PPARa activation through its agonists resulted in reduced body weight by regulating satiety and by ameliorating obesity-derived inflammation in adipose tissue. 38, 39 Although PPARa
mice fed with HFD showed several obesity phenotypes in terms of body weight, fat mass, and fat droplets, 40 the major mechanisms by which PPARa regulates lipid metabolism are regulation of fatty acid cellular uptake and stimulation of fatty acid oxidation. 41 In our studies, enhanced mRNA expression levels of PPARa were consistently detected only in adipose tissues from Atg7 DCD11c mice, FMT mice, and BA-fed mice ( Figure 5 ), indicating that b-oxidation through PPARa signaling may be a mechanism for protection against obesity provoked by specific commensal bacteria such as BA.
In mice, CA, a primary bile acid, is secreted as a taurineconjugated form from the gallbladder into the duodenum and then is deconjugated in the ileum by commensal bacteria. 42 Recent studies have shown that the bile acid profiles in the small intestine, feces, and serum of conventionally raised mice are totally different from those of germ-free mice, suggesting that commensal bacteria can modulate gene expression levels related to bile acid synthesis, conjugation, and reabsorption. 43 In the present study, significantly elevated levels of cholate and taurine were determined in feces ( Figure 6d ) and their receptor TGR5 in adipose tissues (Figure 5e ) of B6 mice fed with BA. Others have shown that when the TGR5 agonists CA and taurine are administered, there is a significant improvement of body weight and fat mass in HFD-fed mice. 22, 44 Those authors suggest that the bile acid-TGR5-cAMP signaling pathways increase energy expenditure in adipose tissue and skeletal muscle. Thus, we propose that bile acids activated by BA serve as ligands for TGR5-mediated regulation of energy expenditure through PPARa activation.
In summary, deletion of Atg7 in CD11c þ cells alters the composition of commensal bacteria, which leads to increased insulin production in serum and b-oxidation in adipose tissues and finally to protection of the host from obesity. Our discovery of the expansion of BA in the gut of Atg7
DCD11c mice suggests that commensal bacteria may be interlinked between autophagy deficiency and lean phenotypes. Although further studies are required to determine the efficiency of BA on diverse combinations of genetic and environment factors, our finding suggest that BA may be a potent tool for metabolic diseases such as diabetes and obesity.
conditions in the animal facility at the Asan Biomedical Research Center (Seoul, Korea) where they received sterilized food and water ad libitum. B. acidifaciens (JCM10556) and B. sartorii (JCM17136) used in this study were purchased from the Japan Collection of Microorganisms (JCM) at RIKEN BioResource Center.
454 pyrosequencing analysis cDNA was extracted from feces using QIAamp DNA stool mini kits (Qiagen, Valencia, CA). PCR amplification was performed using primers targeting the V1 to V3 regions of the 16S rRNA gene with extracted cDNA. For bacterial amplification, we used the barcoded primers of 9F (5 0 -CCTATCCC CTGTGTGCCTTGGCAGTC-TCAG-AC-AGAGTTTGATC MTGGCTCAG-3 0 ; underlined sequence indicates the target region primer) and 541R (5 0 -CCATCTCATCCCTGCGTGT CTCCGAC-TCAG-X-AC-ATTACCGCGGCTGCTGG-3 0 ; ''X'' indicates the unique barcode for each subject) (http://oklbb.ezbiocloud.net/content/1001). The amplifications were done under the following conditions: initial denaturation at 95 1C for 5 min, followed by 30 cycles of denaturation at 95 1C for 30 s, primer annealing at 55 1C for 30 s, and extension at 72 1C for 30 s, with a final elongation at 72 1C for 5 min. The amplified products were purified with the QIAquick PCR purification kit (Qiagen). Equal concentrations of purified products were pooled together, and short fragments (non-target products) were removed with an AMPure bead kit (Agencourt Bioscience, Beverly, MA). The quality and product size were assessed on a Bioanalyzer 2100 (Agilent, Palo Alto, CA) using a DNA 7500 chip. Mixed amplicon sequencing was done by by emulsion PCR and then deposited on picotiter plates. The sequencing was carried out at Chunlab (Seoul, Korea) on a GS Junior Sequencing System (Roche, Branford, CT) according to the manufacturer's instructions. Pyrosequencing data analysis was performed as previously described. 45 
CE-TOF-MS measurement
We performed a quantitative analysis of charged metabolites by CE-TOF-MS as described previously with slight modification. 46 In brief, we disrupted 10 mg of freeze-dried fecal samples using 3-mm zirconia-silica beads (BioSpec Products, Bartlesville, OK) and homogenized them with 400 ml of MeOH containing 20 mM each of methionine sulfone (Wako, Osaka, Japan) for cations, and MES (Dojindo, Kumamoto, Japan) and CSA (D-Camphol-10-sulfonic acid; Wako) for anions as internal standards. Then, 200 ml of de-ionized water and 500 ml of chloroform were added. After vigorous shaking using Shakemaster neo (Bio Medical Science, Tokyo, Japan) at 1,500 r.p.m. for 10 min, the solution was centrifuged at 4,600 g for 15 min at 4 1C and filtered through a Millipore 5000-Da cutoff filter (Millipore, Billerica, MA) to remove proteins. The filtrate was lyophilized and dissolved in 25 ml of water containing 200 mM each of 3-aminopyrrolidine (Sigma-Aldrich, St. Louis, MO) and trimesate (Wako) as reference compounds. All CE-TOF-MS experiments were performed using Agilent Technologies equipment: a CE capillary electrophoresis system, a G3250AA LC/ MSD TOF system, an 1100 series binary HPLC pump, a G1603A CE-MS adapter, and a G1607A CE-ESI-MS sprayer kit. To identify peak annotation and quantification, data were processed using in-house software (MasterHands). 47 
Gas chromatography mass spectrometry measurement
Organic acid concentrations of feces were determined using a GC-mass spectrometer. 48 In brief, aliquots (80 ml) of ether extracts of feces were mixed with 16 ml N-tert-butyldimethylsilyl-N methyltrifluoroacetamide. The vials were sealed tightly, heated at 80 1C for 20 min in a water bath, and then left at room temperature for 48 h for derivatization. The derivatized samples were run through a 6890N Network GC System (Agilent Technologies) equipped with HP-5MS column (0.25 mm Â 30 m Â 0.25 mm) and a 5973 Network Mass Selective Detector (Agilent Technologies). Pure helium (99.9999%) was used as carrier gas and delivered at a flow rate of 1.2 ml min 
Measurement of GLP-1
Blood samples were taken from control and BA-fed mice, and then centrifuged for 30 min at 1,800 g at 4 1C. DPP-4 inhibitor was added, and GLP-1 concentrations were determined using the GLP-1 ELISA kit (Shibayagi, Gunma, Japan).
Measurement of DPP-4
The DPP-4 levels were determined as previously described. 49 In brief, wild-type B6 mice were orally administered BA (5 Â 10 9 CFU per 100 ml) or their culture supernatants (100 ml per head) or culture medium alone with the DPP-4 inhibitor sitagliptin (40 mg per mouse; Merck Sharp Dohme and Chibret Laboratories, Rahway, NJ) after fasting for 6 h and then given glucose 30 min later. After 15 min, intestinal epithelial cells of the ileum were taken from pre-treated mice, and washed with PBS to remove luminal contents. The mucus was removed by gentle scraping, and epithelium was chopped by scissor into 1-2 mm lengths and placed in 1 ml of PBS. The minced tissues were spun down by centrifugation (6,000 g, 4 1C, 5 min), and then 50 ml of the supernatant was incubated with kit reagents for 2 h at 37 1C by DPP-4 Glo protease assay (Promega, Madison, WI). The DPP-4 activity was calculated with the value of control sample in the absence of sitagliptin.
Statistics
GraphPad Prism software (GraphPad, La Jolla, CA) was used for statistical analysis. Significant differences between two groups were analyzed with two-tailed paired t-test or MannWhitney t-test. Multiple groups were analyzed by two-way ANOVA followed by Bonferroni post-hoc test (*Po0.05; **Po0.01; ***Po0.001).
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
